Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia

被引:26
作者
Cheng, S. [1 ]
Teuffel, O. [1 ,2 ,3 ]
Ethier, M. C. [2 ]
Diorio, C. [2 ]
Martino, J. [2 ]
Mayo, C. [2 ]
Regier, D. [2 ]
Wing, R. [2 ]
Alibhai, S. M. H. [4 ,5 ]
Sung, L. [1 ,2 ,3 ]
机构
[1] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
[2] Hosp Sick Children, Program Child Hlth Evaluat Sci, Toronto, ON M6G 1X8, Canada
[3] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M6G 1X8, Canada
[4] Univ Toronto, Dept Internal Med, Toronto, ON M5S 1A1, Canada
[5] Univ Hlth Network, Dept Med, Toronto, ON M5G 2C4, Canada
关键词
health-related quality of life; child; febrile neutropaenia; willingness to pay; visual analogue scale; time trade-off technique; EARLY HOSPITAL DISCHARGE; LOW-RISK; OUTPATIENT MANAGEMENT; CANCER-PATIENTS; ORAL CIPROFLOXACIN; ONCOLOGY PATIENTS; STANDARD GAMBLE; SINGLE-CENTER; CHILDREN; FEVER;
D O I
10.1038/bjc.2011.213
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: To describe (1) anticipated health-related quality of life during different strategies for febrile neutropaenia (FN) management and (2) attributes of those preferring inpatient management. METHODS: Respondents were parents of children 0-18 years and children 12-18 years receiving cancer treatment. Anticipated health-related quality of life was elicited for four different FN management strategies: entire inpatient, early discharge, outpatient oral and outpatient intravenous (i.v.) therapy. Tools used to measure health-related quality of life were visual analogue scale (VAS), willingness to pay and time trade off. RESULTS: A total of 155 parents and 43 children participated. For parents, median VAS scores were highest for early discharge (5.9, interquartile range 4.4-7.2) and outpatient i.v. (5.9, interquartile range 4.4-7.3). For children, median scores were highest for early discharge (6.1, interquartile range 4.6-7.2). In contrast, the most commonly preferred strategy for parents and children was inpatient in 55.0% and 37.2%, respectively. Higher current child health-related quality of life was associated with a stronger preference for outpatient management. CONCLUSION: Early discharge and outpatient i.v. management are associated with higher anticipated health-related quality of life, although the most commonly preferred strategy was inpatient care. This data may help with determining more cost-effective strategies for paediatric FN. British Journal of Cancer (2011) 105, 606-611. doi:10.1038/bjc.2011.213 www.bjcancer.com Published online 21 June 2011 (C) 2011 Cancer Research UK
引用
收藏
页码:606 / 611
页数:6
相关论文
共 34 条
[1]  
[Anonymous], 1953, Theory of games and economic behavior
[2]  
Aquino VM, 2000, CANCER, V88, P1710, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1710::AID-CNCR27>3.3.CO
[3]  
2-T
[4]  
Baorto EP, 2001, CANCER, V92, P909, DOI 10.1002/1097-0142(20010815)92:4<909::AID-CNCR1400>3.0.CO
[5]  
2-H
[6]   QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].
BODEY, GP ;
BUCKLEY, M ;
SATHE, YS ;
FREIREICH, EJ .
ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+
[7]   Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy [J].
Caggiano, V ;
Weiss, RV ;
Rickert, TS ;
Linde-Zwirble, WT .
CANCER, 2005, 103 (09) :1916-1924
[8]   Clinical and laboratory features predicting a favorable outcome and allowing early discharge in cancer patients with low-risk febrile neutropenia: A literature review [J].
Castagnola, E ;
Paola, D ;
Giacchino, R ;
Viscoli, C .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (05) :645-649
[9]   Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting [J].
Dommett, R. ;
Geary, J. ;
Freeman, S. ;
Hartley, J. ;
Sharland, M. ;
Davidson, A. ;
Tulloh, R. ;
Taj, M. ;
Stoneham, S. ;
Chisholm, J. C. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (16) :2843-2849
[10]   PHARMACOECONOMIC ANALYSIS OF EMPIRICAL THERAPY WITH CEFTAZIDIME ALONE OR COMBINATION ANTIBIOTICS FOR FEBRILE NEUTROPENIA IN CANCER-PATIENTS [J].
DRANITSARIS, G ;
TRAN, TM ;
MCGEER, A ;
NARINE, L .
PHARMACOECONOMICS, 1995, 7 (01) :49-62